top of page

Cellular Therapy Coding and Labeling Advisory Group

OVERVIEW

​

​

The Cellular Therapy Coding and Labeling Advisory Group (CTCLAG) was established in 2004. Its purpose is to advise ICCBBA of the needs of cellular therapy organizations for coding and labeling. Membership comprises representatives from major cellular therapy professional organizations: AABB, APBMT, ASTCT, ASFA, EBMT, FACT, ISBT, ISCT, JACIE, NMDP and WMDA. Additionally, the group has invited technical experts to serve as voting members on the group.

​

Liaisons from other organizations, primarily representing regulatory bodies, also attend meetings. 

​

Vendors and other interested parties attend meetings as observers at the discretion of the chairperson.

​

CTCLAG Joint Statement - PDF

SUMMARY OF RECENT ACTIVITY

​

​

CTCLAG met face-to-face on October 18, 2024, in Houston, Texas. This was the group's first in-person meeting since June 2015. The group continues to schedule monthly conference calls.

 

The committee is discussing multiple topics, including nomenclature for extracellular vesicles, implementation perspectives on the ISBT 128 Standard Chain of Identity Identifier (ST-028), and updating the United States Consensus Guidance for the Uniform Labeling of Cellular Therapy Products Using ISBT 128 (IG-003).

 

ICCBBA hosted a webinar on the ISBT 128 CoI Identifier on September 24, 2024. The webinar featured external speakers from Stanford Health Care and Beam Therapeutics. The speakers shared CoI Identifier implementation perspectives from the collection/treatment center and the cell therapy manufacturer.

 

CTCLAG's 20th Anniversary is this year, and ICCBBA is scheduling an in-person meeting in New Orleans in May.

​

CTCLAG MEMBER LIST

Chair

​

  • Indreshpal Kaur

Representatives

​

  • Tamara Anderson - National Marrow Donor Program (NMDP) (Alt.)

  • Lou J. Bartolo - National Marrow Donor Program (NMDP) 

  • Geoffrey Behrens - World Marrow Donor Association

  • Christina Celluzzi - Association for the Advancement of Blood & Biotherapies

  • Marcos Hernández - Latin American Bone Marrow Transplantation Group

  • William Hwang - Asia Pacific Blood and Marrow Transplantation

  • Mickey Koh - International Society of Blood Transfusion 

  • Shannon Mack - American Society for Apheresis

  • Samuel A. Molina - American Red Cross

  • Julia Palma - Latin American Bone Marrow Transplantation Group (Alt.)

  • Leigh Sims Poston - International Society Cell & Gene Therapy

  • Lex Van Der Gouw - European Group for Blood and Marrow Transplantation/ Joint Accreditation Committee ISCT-Europe & EBMT

  • Phyllis Warkentin - Foundation for the Accreditation of Cellular Therapy

Technical Experts

​

  • Brenda Alder

  • Betty Dogget

  • Beth Gardner

  • Joshua Geary

  • Kathy Loper

  • Anna Persson

  • Zbigniew Szczepiorkowski

  • Yossi Schwartz

Liaisons

​​

  • TBD – European Commission

  • Kathleen Hopping - ATAG

  • Izabela Uhrynowska-Tyszkiewicz – TTAG

  • Martin FitzGerald - GS1

Observers
​​

  • Erica Agy

  • David Barwin

  • Geoff Browne

  • Lee Buckler

  • Melissa Burt

  • Tim Costello

  • Jeff Dragoo

  • Katona Atilla Ferenc

  • Clement Glinkowski

  • John Gorowsky

  • Kimberly Jimenez

  • Brian Kirkpatrick

  • John Kling

  • Dan Leberfinger

  • John Muicroft

  • Mikhaila Roe

  • David Steiner

  • Daniel Waurzyniak

  • Renae Weaver

  • Tomasz Wojcicki

ICCBBA Staff Liaison

​

  • Erwin Cabana

bottom of page